• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
CFI-400945

CFI-400945

Product ID C211324
Cas No. 1338806-73-7
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $102.30 In stock
5 mg $204.40 In stock
25 mg $511.10 In stock
100 mg $1,465.00 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

CFI-400945 is an inhibitor of polo-like kinase 4 (PLK4). PLK4 plays an important role in centriole replication, and inhibition of PLK4 disrupts mitosis. CFI-400945 inhibits tumor growth in models of pancreatic cancer. PLK4 inhibition may be effective against osteosarcoma, where it is theorized that overexpression of PLK4 may be a driving force in osteosarcoma development and preservation.

Product Info

Cas No.

1338806-73-7

Purity

≥98%

Formula

C33H34N4O3

Formula Wt.

534.66

Chemical Name

(1R,2S)-2-{3-[(E)-2-(4-{[(2R,6S)-2,6-Dimethyl-4-morpholinyl]methyl}phenyl)vinyl]-1H-indazol-6-yl}-5'-methoxyspiro[cyclopropane-1,3'-indol]-2'(1'H)-one

IUPAC Name

(1R,2S)-2-{3-[(E)-2-(4-{[(2R,6S)-2,6-Dimethyl-4-morpholinyl]methyl}phenyl)vinyl]-1H-indazol-6-yl}-5'-methoxyspiro[cyclopropane-1,3'-indol]-2'(1'H)-one

Synonym

CFI 400945, CFI400945, CFI-400945 (free base)

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

C211324 MSDS PDF

Info Sheet

C211324 Info Sheet PDF

References

Lohse I., Mason J., et al. Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts. Oncotarget. 8(2):3064-71 (2017). PMID: 27902970.

Kelleher F., Kores J., et al. Targeting the centrosome and polo-like kinase 4 in osteosarcoma. Carcinogenesis. 40(4):493-99 (2019). PMID: 30508038.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • F0275

    Fasudil Hydrochloride

    ROCK inhibitor.

    ≥98%
  • H0002

    H8 dihydrochloride

    PKA inhibitor.

    ≥98%
  • P7057

    Protodioscin

    Saponin found in Dioscorea; Na+/K+ ATPase and C...

    ≥98%
  • R2815

    Recombinant HIV-1 “0” group consensus

    Recombinant HIV-1 antigen fragment.

    ≥95%
  • S8005

    Substance P

    Endogenous tachykinin peptide, involved in infl...

    ≥95%
  • M0272

    Mastoparan 7

    Antimicrobial peptide found in bee and wasp ven...

    ≥95%
  • L8377

    Luteolin

    Flavonoid found in various plant sources; DAT a...

    ≥95%
  • L1817

    Leflunomide

    AhR agonist, dihydroorotate dehydrogenase inhib...

    ≥98%
  • C0275

    Castanospermine

    O-GlcNAcase inhibitor.

    ≥98%
  • T0109

    13-Acetyl-9-dihydrobaccatin-III

    Found in Taxus, starting material for synthesis...

    ≥98%
  • D6958

    Droloxifene Citrate

    Tamoxifen analog; SERM.

    ≥98%
  • A9602

    Azacitidine

    Nucleoside (cytidine) analog; DNMT inhibitor, p...

    ≥98%
  • D0244

    Dalcetrapib

    Cholesterol ester transfer protein inhibitor.

    ≥98%
  • B4517

    Bleomycin A5 Hydrochloride

    Glycopeptide, induces DNA strand breaks.

    ≥90%
  • T7134

    trans-3,4′,5-Trimethoxy Stilbene

    Resveratrol prodrug; potential SIRT1 activator....

    ≥99%
  • T5604

    Tobramycin, Free Base

    Aminoglycoside; protein translation inhibitor.<...

    ≥98%
  • E5210

    Endomorphin-1

    Endogenous opioid peptide; μOr agonist.

    ≥95%
  • T3132

    Thiazovivin

    ROCK inhibitor.

    ≥98%
  • V1745

    Veliparib

    PARP inhibitor.

    ≥99%
  • F4682

    Fluconazole

    Triazole; 14-α demethylase inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only